Larvol Delta - Chemomab-Reports-Positive-Results-in-Nebokitug-Phase-2-PSC-Open-Label-Extension-Trial-Showing-Continued-Broad-and-Substantial-Improvements-in-Key-Liver-Biomarkers

nebokitug intravenous (CM-101 intravenous) - ChemomAb

https://www.globenewswire.com/news-release/2025/03/27/3050541/0/en/Chemomab-Reports-Positive-Results-in-Nebokitug-Phase-2-PSC-Open-Label-Extension-Trial-Showing-Continued-Broad-and-Substantial-Improvements-in-Key-Liver-Biomarkers.html

Mar 27, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next